Statements March 27, 2025
Innovative Medicines Canada’s Response to Quebec’s 2025-26 Budget
Industry Association Applauds Commitment to the Stratégie Québécoise des sciences de la vie (2025-2028) and to Pharmaceuticals in Hospital Settings […]
All News
Our news library that includes all press releases and industry related news.
Filter by
Statements February 03, 2025
Innovative Medicines Canada Welcomes Patrick Hupé as Vice President of Government and Stakeholder Relations
Ottawa, February 3, 2025 – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President […]
Statements December 16, 2024
Statement from Innovative Medicines Canada on the Release of the 2024 Federal Fall Economic Statement
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
Statements November 15, 2024
Statement from Innovative Medicines Canada on the Committee of Experts to make recommendations on National Pharmacare
We are disappointed to see that, once again, the government has excluded the pharmaceutical industry’s voice from important discussions on […]
Statements October 15, 2024
Statement from Innovative Medicines Canada on Ontario’s Next Phase of the Life Sciences Strategy
Today’s announcement by the Ontario government of a $146 million investment in the next phase of the Life Sciences Strategy […]
Statements October 11, 2024
Statement from Innovative Medicines Canada on the passage of Bill C-64, the Pharmacare Act
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Press Release October 03, 2024
Statement from Innovative Medicines Canada in response to Minister Holland’s letter to SOCI
“Minister Holland’s recent letter to SOCI regarding the impact of Bill C-64 on private insurance in Canada confirms our concerns: […]
Statements September 25, 2024
IMC welcomes the Government of Canada’s announcement on the Launch of Health Emergency Readiness Canada (HERC)
Ottawa, September 25, 2024 – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the […]
Statements July 24, 2024
Innovative Medicines Canada welcomes bilateral agreements between the Government of Canada and Province of British Columbia to improve patient access to drugs for rare diseases
Ottawa, July 24, 2024 – Innovative Medicines Canada (IMC) is encouraged by the announcement that the federal government and the […]
Statements July 17, 2024
Innovative Medicines Canada Urges Provinces to Accelerate Access to Medicines
Ottawa, July 17, 2024 – Innovative Medicines Canada (IMC) is committed to working with and supporting provincial governments to ensure […]
Statements April 16, 2024
Innovative Medicines Canada statement on Federal Budget 2024
Ottawa, April 16, 2024 – Innovative Medicines Canada (IMC) remains concerned that the government’s proposed pharmacare model will not increase […]
Statements February 29, 2024
Innovative Medicines Canada statement on proposed pharmacare legislation
Ottawa, February 29, 2024 – Innovative Medicines Canada (IMC) is concerned with the federal government’s intent in Bill C-64, An […]
